Inovio Pharmaceuticals
125 hedge funds and large institutions have $184M invested in Inovio Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 55 increasing their positions, 17 reducing their positions, and 14 closing their positions.
224% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 17
90% more call options, than puts
Call options by funds: $2.27M | Put options by funds: $1.2M
57% more first-time investments, than exits
New positions opened: 22 | Existing positions closed: 14
6% more funds holding
Funds holding: 118 → 125 (+7)
5% more capital invested
Capital invested by funds: $176M → $184M (+$8.52M)
0.18% more ownership
Funds ownership: 2.5% → 2.69% (+0.18%)
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$9.86M |
| 2 |
BlackRock
New York
|
+$7.55M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$3.67M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.43M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.27M |
Top Sellers
| 1 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$744K |
| 2 |
TCM
Tanaka Capital Management
New York
|
-$688K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$618K |
| 4 |
Goldman Sachs
New York
|
-$582K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$326K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DTL
126
Dynamic Technology Lab
Singapore
| – | -$197K | -2,101 | Closed |
|
127
Group One Trading
Chicago,
Illinois
| – | -$140K | -1,882 | Closed |
|
128
AQR Capital Management
Greenwich,
Connecticut
| – | -$144K | -1,526 | Closed |
|
|
BCM
129
BlueCrest Capital Management
St Helier,
Jersey
| – | -$107K | -1,135 | Closed |
|
|
SBIA
130
Sheaff Brock Investment Advisors
Indianapolis,
Indiana
| – | -$97K | -1,033 | Closed |
|
131
Creative Planning
Overland Park,
Kansas
| – | -$67K | -716 | Closed |
|
|
CLOS
132
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
| – | -$16K | -167 | Closed |
|
|
BCFS
133
Butensky & Cohen Financial Security
Ponte Vedra Beach,
Florida
| – | -$6K | -63 | Closed |
|
|
PA
134
Parallel Advisors
San Francisco,
California
| – | -$2K | -25 | Closed |
|
|
NFG
135
Next Financial Group
Houston,
Texas
| – | -$1K | -9 | Closed |
|
|
TWA
136
TCI Wealth Advisors
Tucson,
Arizona
| – | -$1K | -8 | Closed |
|
|
LC
137
Landaas & Company
Milwaukee,
Wisconsin
| – | +$149 | +2 | New |
|
INO Hedge Fund Activity: Q3 2017 in Review
125 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Inovio Pharmaceuticals (INO) for Q3 2017, worth a combined $184M — up 4.8% from $176M a quarter earlier.
Buyers outnumbered sellers: 22 funds opened new INO positions and 14 closed out — a net gain of 8 holders — while 55 added to existing stakes and 17 trimmed.
The largest buyer was State Street, adding an estimated $9.86M. The largest seller was Candriam SCA, cutting an estimated $744K.
- 125 institutional investors held Inovio Pharmaceuticals (INO) as of Q3 2017, up from 118 in Q2 2017.
- Funds reported $184M of Inovio Pharmaceuticals stock for Q3 2017, up 4.8% quarter-over-quarter.
- 22 funds opened new Inovio Pharmaceuticals positions in Q3 2017 and 14 closed out, a net change of +8 holders.
- The largest Inovio Pharmaceuticals buyer in Q3 2017 was State Street, an estimated $9.86M added.
- The largest Inovio Pharmaceuticals seller in Q3 2017 was Candriam SCA, an estimated $744K sold.
Based on aggregated 13F filings for Q3 2017.